INVO Fertility (IVF) Total Debt Growth (3y) (2019 - 2026)
INVO Fertility (IVF) Total Debt Growth (3y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 24.63% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 4.89% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 4.70% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 11.72% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 0.11% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -0.47% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -1.01% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -13.48% |
| 10 | INVO Fertility | 2.38 Mn | 2.38 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 53.11% |
| Dec 31, 2025 | 98.27% |
| Dec 31, 2024 | 100.03% |
| Sep 30, 2024 | 208.17% |
| Jun 30, 2024 | 144.94% |
| Mar 31, 2024 | 171.55% |
| Dec 31, 2023 | 91.32% |
| Dec 31, 2022 | 197.98% |
| Dec 31, 2021 | 268.15% |
| Sep 30, 2021 | 292.82% |
| Jun 30, 2021 | 23.80% |
| Mar 31, 2021 | 12.08% |
| Dec 31, 2020 | 32.94% |
| Dec 31, 2019 | -42.75% |
| Sep 30, 2019 | -42.96% |